These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27568681)

  • 1. Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers.
    Giusti L; Ciregia F; Mazzoni MR; Lucacchini A
    Expert Rev Proteomics; 2016 Oct; 13(10):941-950. PubMed ID: 27568681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders.
    Preece RL; Han SYS; Bahn S
    Expert Rev Proteomics; 2018 Apr; 15(4):325-340. PubMed ID: 29466886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
    Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived stress and hair cortisol: Differences in bipolar disorder and schizophrenia.
    Streit F; Memic A; Hasandedić L; Rietschel L; Frank J; Lang M; Witt SH; Forstner AJ; Degenhardt F; Wüst S; Nöthen MM; Kirschbaum C; Strohmaier J; Oruc L; Rietschel M
    Psychoneuroendocrinology; 2016 Jul; 69():26-34. PubMed ID: 27017430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies.
    Al Shweiki MR; Oeckl P; Steinacker P; Hengerer B; Schönfeldt-Lecuona C; Otto M
    Expert Rev Proteomics; 2017 Jun; 14(6):499-514. PubMed ID: 28562112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactome Studies of Psychiatric Disorders.
    Park DI; Turck CW
    Adv Exp Med Biol; 2019; 1118():163-173. PubMed ID: 30747422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomics for investigating psychiatric disorders.
    Filiou MD; Turck CW; Martins-de-Souza D
    Proteomics Clin Appl; 2011 Feb; 5(1-2):38-49. PubMed ID: 21280236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood.
    Cattane N; Minelli A; Milanesi E; Maj C; Bignotti S; Bortolomasi M; Bocchio Chiavetto L; Gennarelli M
    PLoS One; 2015; 10(2):e0116686. PubMed ID: 25658856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplifying the human serum proteome for discriminating patients with bipolar disorder of other psychiatry conditions.
    de Jesus JR; Galazzi RM; de Lima TB; Banzato CEM; de Almeida Lima E Silva LF; de Rosalmeida Dantas C; Gozzo FC; Arruda MAZ
    Clin Biochem; 2017 Dec; 50(18):1118-1125. PubMed ID: 28662995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review and Meta-Analysis of Mass Spectrometry Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Schizophrenia.
    Rodrigues JE; Martinho A; Santa C; Madeira N; Coroa M; Santos V; Martins MJ; Pato CN; Macedo A; Manadas B
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia.
    Forstner AJ; Hecker J; Hofmann A; Maaser A; Reinbold CS; Mühleisen TW; Leber M; Strohmaier J; Degenhardt F; Treutlein J; Mattheisen M; Schumacher J; Streit F; Meier S; Herms S; Hoffmann P; Lacour A; Witt SH; Reif A; Müller-Myhsok B; Lucae S; Maier W; Schwarz M; Vedder H; Kammerer-Ciernioch J; Pfennig A; Bauer M; Hautzinger M; Moebus S; Schenk LM; Fischer SB; Sivalingam S; Czerski PM; Hauser J; Lissowska J; Szeszenia-Dabrowska N; Brennan P; McKay JD; Wright A; Mitchell PB; Fullerton JM; Schofield PR; Montgomery GW; Medland SE; Gordon SD; Martin NG; Krasnov V; Chuchalin A; Babadjanova G; Pantelejeva G; Abramova LI; Tiganov AS; Polonikov A; Khusnutdinova E; Alda M; Cruceanu C; Rouleau GA; Turecki G; Laprise C; Rivas F; Mayoral F; Kogevinas M; Grigoroiu-Serbanescu M; Becker T; Schulze TG; Rietschel M; Cichon S; Fier H; Nöthen MM
    PLoS One; 2017; 12(2):e0171595. PubMed ID: 28166306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of proteomics in diagnosis of ADHD, schizophrenia, major depression, and suicidal behavior.
    Alawam K
    Adv Protein Chem Struct Biol; 2014; 95():283-315. PubMed ID: 24985776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics strategies for bipolar disorder evaluation: From sample preparation to validation.
    de Jesus JR; Pessôa GS; Sussulini A; Martínez JLC; Arruda MAZ
    J Proteomics; 2016 Aug; 145():187-196. PubMed ID: 27113133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Discovery of Clinically Applicable Biomarkers for Bipolar Disorder: A Review of Candidate and Proteomic Approaches.
    Muneer A
    Chonnam Med J; 2020 Sep; 56(3):166-179. PubMed ID: 33014755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future.
    Comes AL; Papiol S; Mueller T; Geyer PE; Mann M; Schulze TG
    Transl Psychiatry; 2018 Aug; 8(1):160. PubMed ID: 30115926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Molecular Appreciation of Psychiatric Disorders Through High-Dimensionality Data Acquisition and Analytics.
    van Gastel J; Hendrickx JO; Leysen H; Martin B; Veenker L; Beuning S; Coppens V; Morrens M; Maudsley S
    Methods Mol Biol; 2019; 2011():671-723. PubMed ID: 31273728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Proteomic Measures Across Serious Psychiatric Illness.
    Schulz SC; Overgaard S; Bond DJ; Kaldate R
    Clin Schizophr Relat Psychoses; 2017; 11(2):103-112. PubMed ID: 28742394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric disorders biochemical pathways unraveled by human brain proteomics.
    Saia-Cereda VM; Cassoli JS; Martins-de-Souza D; Nascimento JM
    Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):3-17. PubMed ID: 27377417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.
    Lozupone M; Seripa D; Stella E; La Montagna M; Solfrizzi V; Quaranta N; Veneziani F; Cester A; Sardone R; Bonfiglio C; Giannelli G; Bisceglia P; Bringiotti R; Daniele A; Greco A; Bellomo A; Logroscino G; Panza F
    Expert Rev Proteomics; 2017 Sep; 14(9):809-824. PubMed ID: 28870126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.